Search

everythinglearnresearchcommunity

for

Search:↓

Prenatal stress changes how male and female rats enjoy rewards differently, linked to sex hormones.

As skin ages, it gets thinner, paler, and more wrinkled, and protection and care like sunblock and moisturizers are important.

CAG repeat polymorphism and prostate zone volume are not reliable markers of long-term androgen sensitivity.

Finasteride reduces prostate cancer risk but may affect ejaculatory volume and requires careful consideration for young men.

Certain finger length ratios and body hair patterns may predict side effects from birth control pills in women.

Hormones, especially DHT, affect hair loss and growth, and targeting specific enzymes may help treat hair loss.

The new rodent model successfully mimics non-lean human PCOS symptoms.

Testosterone affects blood pressure control and inflammation in male rats with endotoxic shock, and blocking certain hormones may help treat it.

Androgenetic alopecia is common hair loss caused by genetics and hormones, with treatments to slow it but no cure.

The paper concludes that animal models help in understanding hair loss causes and developing new treatments.

Men with male pattern baldness may not have different hormone levels, but their hair follicles are likely more sensitive to hormones.

The engineered yeast strain BLYAS can quickly and sensitively detect androgenic chemicals.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Using 5-butylpicolinate esters improves the sensitivity and reliability of detecting testosterone and dihydrotestosterone in saliva.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Male pattern hair loss affects up to 80% of men due to genetics and hormone sensitivity.

A new method accurately measures nine steroid hormones in human serum with high sensitivity.

Androgenetic alopecia is a common type of hair loss in men and women, caused by a testosterone byproduct affecting hair follicles, with sensitivity determined by genetics.

Effective treatments for hair loss include minoxidil, 5α-reductase inhibitors, and personalized combination therapies.

Two drugs, finasteride and minoxidil, are approved for hair loss treatment, but new therapies are being developed.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Hirsutism in females is caused by high male hormones or sensitive hair follicles.

The new model mimics hair loss and helps test treatments.

Hair loss can be managed with treatments like minoxidil, finasteride, and others, but there are still gaps in effectiveness and off-label usage is increasing.

Hirsutism in women can be a cosmetic issue or a sign of hormonal imbalance, treatable with hormonal and cosmetic methods.

Taking 1 mg finasteride for a year reduces dihydrotestosterone levels in men with early hair loss, but doesn't change their metabolic state.

Excessive pre-ejaculation can be treated with certain medications.

Androgenetic alopecia is common hair loss due to genetics and hormones, manageable with early treatment.

Male pattern baldness is a common hair loss in men caused by genetics and hormones, with treatments including drugs, hair transplants, and hair loss products.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.